Mary Elizabeth Fowler is a prominent inventor based in Somerville, MA (US). She has made significant contributions to the field of biotransformation and glycosylation, holding two patents that showcase her innovative work.

Latest Patents

Fowler's latest patents focus on the production of steviol glycosides through whole cell biotransformation of steviol glycoside intermediates. In various aspects and embodiments, her inventions provide microbial cells and methods for producing advanced glycosylation products from lower glycosylated intermediates. The microbial cells express one or more UDP-dependent glycosyl transferase enzymes in the cytoplasm, facilitating the glycosylation of the intermediates. When incubating the microbial strain with a plant extract or fraction comprising the intermediates, these glycosylated intermediates become available for further glycosylation by the cell. The advanced glycosylation products can then be recovered from the media and/or microbial cells.

Career Highlights

Mary Elizabeth Fowler is currently associated with Manus Bio Inc., where she continues to advance her research and development efforts in glycosylation technology. Her work has the potential to impact various industries, including food and pharmaceuticals.

Collaborations

Fowler collaborates with notable colleagues such as Ajikumar Parayil Kumaran and Christine Nicole S Santos, contributing to a dynamic research environment that fosters innovation.

Conclusion

Mary Elizabeth Fowler's contributions to the field of glycosylation through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in biotransformation technologies.

Profile summary based on public USPTO records.